Form EFFECT ADARx Pharmaceuticals,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 24, 2026 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MissionIRNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRAP) Expands Public Safety Strategy Beyond Law Enforcement
- GOWell Technology Limited and Inflection Point Acquisition Corp. V Announce Closing of Business Combination
- D. Boral Capital Acted as Bookrunner to Leader's Advantage Acquisition Corp. (Nasdaq:LEDRU) in Connection with its $150,000,000 Million Initial Public Offering
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
